Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered

Table 3 Correlation between Emean and liver condition with different alanine aminotransferase

Parameter	Pos group				Neg group
	ALT ≤ 40 U/L, n = 122		ALT > 40 U/L, n = 78		ALT ≤ 40 U/L, n = 71		ALT > 40 U/L, n = 13
	r	P value	r	P value	r	P value	r	P value
CP score	0.22	0.016a	0.23	0.044a	0.31	0.009b	0.23	0.447
CP grade	0.2	0.030a	0.21	0.065	0.2	0.102	0.23	0.447
ALBI score	0.29	0.001b	0.36	0.001b	0.35	0.003b	0.06	0.855
ALBI grade	0.21	0.018a	0.27	0.018a	0.23	0.054	0.39	0.182
MELD	-0.06	0.508	-0.08	0.48	0.18	0.125	0.02	0.945
TBIL	0.14	0.127	0.13	0.264	0.25	0.036a	0.09	0.779
ALB	-0.24	0.007b	-0.29	0.009b	-0.29	0.015a	-0.1	0.817
PT	0.43	< 0.001b	0.33	0.004b	0.28	0.018a	0.07	0.811

^aP < 0.05.

^bP < 0.01. ALB: Albumin; ALBI: Albumin-bilirubin; MELD: Model for end-stage liver disease; ALT: Alanine aminotransferase; CP: Child-Pugh; HBV: Hepatitis B virus; Neg group: HBV-DNA negative group; Pos group: HBV-DNA positive group; PT: Prothrombin time; TBIL: Total bilirubin.